Polak et al. [12] found similar results in a different breast cancer cohort, and pointed out that cancers carrying a somatic event in BRCA1 (n = 36, cohort size = 995) or BRCA2 (n = 34, 995) had a stronger contribution from CS-3. The gene discussed is BRCA1; the disease is cancer.